Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
78,02 €
He provides a rationale for underpowered phase 2 trials based on the notion of efficiency, which leads to the identification of an admissible family of phase 2 designs. This approach is based on the ratio of power to type 1 error and transcends typical Bayesian and frequentist statistical analyses.
Jetzt bei Ebay:
![Produktbild - Advanced Survival Models (Chapman & Hall/CRC Biostatistics Series) [Paperback]](https://i.ebayimg.com/thumbs/images/g/OA0AAOSwrM9nihfk/s-l140.jpg)
